Looking back on a distinguished career – Professor David Dearnaley 27 Oct 2020 After an acclaimed career spanning more than 40 years, Professor David Dearnaley, Professor of Uro-Oncology at the ICR and Consultant Clinical Oncologist at The Royal Marsden, has retired. His work has changed best practice on a global level, impacting the lives of an untold number of cancer patients and advancing cancer research. Find out more Show/Hide
Men’s Health Awareness Month: 12 months of progress into male cancer research at the ICR 21 Nov 2019 November is Men’s Health Awareness Month, an important time to raise awareness of male cancers. Our Web Editor, Dave Morgan, looks into six advances made by our researchers into prostate, testicular and urological cancers in the last year. Find out more Show/Hide
How will a clinical trial called CHHiP affect the future of prostate radiotherapy? 02 Aug 2018 Men with prostate cancer can now face a much less daunting course of radiotherapy thanks to the CHHiP clinical trial. Our Cancer Stories Officer, Lydia Brain, spoke with Derek Tomlin, a patient whose treatment was influenced by CHHiP, to find out how the trial could improve the experience of prostate cancer patients in the future. Find out more Show/Hide